These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28816009)

  • 1. Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.
    Song S; Ji Y; Zhang G; Zhang X; Li B; Li D; Jiang W
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):199-207. PubMed ID: 28816009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
    Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
    Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
    Zhang L; Ji YX; Jiang WL; Lv CJ
    Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oral atazanavir attenuates myocardial infarction-induced cardiac fibrosis.
    Zhang G; Zhang X; Li D; Tian J; Jiang W
    Eur J Pharmacol; 2018 Jun; 828():97-102. PubMed ID: 29605419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
    J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.
    Zhao H; Qin HY; Cao LF; Chen YH; Tan ZX; Zhang C; Xu DX
    Toxicol Lett; 2015 Jan; 232(1):213-20. PubMed ID: 25455454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
    Divya T; Velavan B; Sudhandiran G
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
    Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
    Qu Y; Zhang L; Kang Z; Jiang W; Lv C
    Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition.
    Cui W; Li L; Li D; Mo X; Zhou W; Zhang Z; Xu L; Zhao P; Qi L; Li P; Gao J
    Inflamm Res; 2015 Dec; 64(12):953-61. PubMed ID: 26411348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21.
    Zhou X; Li YJ; Gao SY; Wang XZ; Wang PY; Yan YF; Xie SY; Lv CJ
    J Cell Mol Med; 2015 May; 19(5):1103-13. PubMed ID: 25704671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIP/PAP protects against bleomycin-induced lung injury and inflammation and subsequent fibrosis in mice.
    Zheng X; Li Q; Tian H; Li H; Lv Y; Wang Y; He L; Huo Y; Hao Z
    J Cell Mol Med; 2020 Jun; 24(12):6804-6821. PubMed ID: 32352211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mushroom Inonotus sanghuang alleviates experimental pulmonary fibrosis: Implications for therapy of pulmonary fibrosis.
    Su X; Liu K; Xie Y; Zhang M; Wu X; Zhang Y; Wang J
    Biomed Pharmacother; 2021 Jan; 133():110919. PubMed ID: 33202282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
    Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forsythoside A regulates pulmonary fibrosis by inhibiting endothelial-to-mesenchymal transition and lung fibroblast proliferation via the PTPRB signaling.
    Zhang Q; Zhang B; Yang F; Hu Y; Fan R; Wang M; Chen S
    Phytomedicine; 2024 Jul; 130():155715. PubMed ID: 38788399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
    Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
    Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high mobility group box1 in pulmonary fibrosis.
    Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.